BioMedPartners
BioMedInvest AG I
Portfolio BioMedInvest AG I
Board of Directors
News
Investors Access
BioMedInvest AG II
Portfolio BioMedInvest AG II
Board of Directors
News
BioMedCredit AG
Portfolio
Board of Directors
News
Investors Access
Team
Investment Team
Venture Partners
Advisors
Office
Ethical Values
Contact
How to find us
Imprint and Disclaimer
Sitemap
Portfolio BioMedInvest AG I
Private Companies
IPOs / M&A
Board of Directors
News
Investors Access
Vivendy Therapeutics AG
Vivendy Therapeutics AG develops enzyme replacement therapy (ERT) for Morbus Morquio.
www.vivendy.ch
© BioMedPartners 2007
